Skip to main content
Log in

Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome

  • Original Article
  • Published:
Neurogenetics Aims and scope Submit manuscript

Abstract

Velocardiofacial/DiGeorge syndrome (VCFS/DGS) is a developmental disorder caused by a 1.5 to 3-Mb hemizygous 22q11.2 deletion. VCFS/DGS patients display malformations in multiple systems, as well as an increased frequency of neuropsychiatric defects including schizophrenia. Haploinsufficiency of TBX1 appears to be responsible for these physical malformations in humans and mice, but the genes responsible for the neuropsychiatric defects are unknown. In this study, two mouse models of VCFS/DGS, a deletion mouse model (Lgdel/+) and a single gene model (Tbx1 +/−), as well as a third mouse mutant (Gscl −/−) for a gene within the Lgdel deletion, were tested in a large behavioral battery designed to assess gross physical features, sensorimotor reflexes, motor activity nociception, acoustic startle, sensorimotor gating, and learning and memory. Lgdel/+ mice contain a 1.5-Mb hemizygous deletion of 27 genes in the orthologous region on MMU 16 and present with impairment in sensorimotor gating, grip strength, and nociception. Tbx1 +/− mice were impaired in grip strength similar to Lgdel/+ mice and movement initiation. Gscl −/− mice were not impaired in any of the administered tests, suggesting that redundant function of other Gsc family members may compensate for the loss of Gscl. Thus, although deletion of the genes in the Lgdel region in mice may recapitulate some of the behavioral phenotypes seen in humans with VCFS/DGS, these phenotypes are not found in mice with complete loss of Gscl or in mice with heterozygous loss of Tbx1, suggesting that the neuropsychiatric and physical malformations of VCFS/DGS may act by different genetic mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

VCFS/DGS:

Velocardiofacial/DiGeorge syndrome

MMU16:

Mouse chromosome 16

CS:

Conditioned stimulus

US:

Unconditioned stimulus

References

  1. Anagnostaras SG, Gale GD, Fanselow MS (2001) Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11:8–17

    Article  PubMed  CAS  Google Scholar 

  2. Baldini A (2002) DiGeorge syndrome: the use of model organisms to dissect complex genetics. Hum Mol Genet 11:2363–2369

    Article  PubMed  CAS  Google Scholar 

  3. Baldini A (2005) Dissecting contiguous gene defects: TBX1. Curr Opin Genet Dev 15:279–284

    Article  PubMed  CAS  Google Scholar 

  4. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R (2003) The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 160:1580–1586

    Article  PubMed  Google Scholar 

  5. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O’Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107

    Article  PubMed  Google Scholar 

  6. Burn J, Takao A, Wilson D, Cross I, Momma K, Wadey R, Scambler P, Goodship J (1993) Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 30:822–824

    PubMed  CAS  Google Scholar 

  7. Cohen E, Chow EW, Weksberg R, Bassett AS (1999) Phenotype of adults with the 22q11 deletion syndrome: a review. Am J Med Genet 86:359–365

    Article  PubMed  CAS  Google Scholar 

  8. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L (1979) The spectrum of the DiGeorge syndrome. J Pediatr 94:883–890

    Article  PubMed  CAS  Google Scholar 

  9. Corbo JC, Deuel TA, Long JM, LaPorte P, Tsai E, Wynshaw-Boris A, Walsh CA (2002) Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J Neurosci 22:7548–7557

    PubMed  CAS  Google Scholar 

  10. Driscoll DA, Budarf ML, Emanuel BS (1992) A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 50:924–933

    PubMed  CAS  Google Scholar 

  11. Epstein JA (2001) Developing models of DiGeorge syndrome. Trends Genet 17:S13–S17

    Article  PubMed  CAS  Google Scholar 

  12. Galili N, Epstein JA, Leconte I, Nayak S, Buck CA (1998) Gscl, a gene within the minimal DiGeorge critical region, is expressed in primordial germ cells and the developing pons. Dev Dyn 212:86–93

    Article  PubMed  CAS  Google Scholar 

  13. Gerdes M, Solot C, Wang PP, Moss E, LaRossa D, Randall P, Goldmuntz E, Clark BJ 3rd, Driscoll DA, Jawad A, Emanuel BS, McDonald-McGinn DM, Batshaw ML, Zackai EH (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85:127–133

    Article  PubMed  CAS  Google Scholar 

  14. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95:9991–9996

    Article  PubMed  CAS  Google Scholar 

  15. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M (1999) The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434–439

    Article  PubMed  CAS  Google Scholar 

  16. Greenberg F, Crowder WE, Paschall V, Colon-Linares J, Lubianski B, Ledbetter DH (1984) Familial DiGeorge syndrome and associated partial monosomy of chromosome 22. Hum Genet 65:317–319

    Article  PubMed  CAS  Google Scholar 

  17. Jerome LA, Papaioannou VE (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286–291

    Article  PubMed  CAS  Google Scholar 

  18. Kimber WL, Hsieh P, Hirotsune S, Yuva-Paylor L, Sutherland HF, Chen A, Ruiz-Lozano P, Hoogstraten-Miller SL, Chien KR, Paylor R, Scambler PJ, Wynshaw-Boris A (1999) Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum Mol Genet 8:2229–2237

    Article  PubMed  CAS  Google Scholar 

  19. LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155–184

    Article  PubMed  CAS  Google Scholar 

  20. Liao J, Kochilas L, Nowotschin S, Arnold JS, Aggarwal VS, Epstein JA, Brown MC, Adams J, Morrow BE (2004) Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 13:1577–1585

    Article  PubMed  CAS  Google Scholar 

  21. Lindsay EA (2001) Chromosomal microdeletions: dissecting del22q11 syndrome. Nat Rev Genet 2:858–868

    Article  PubMed  CAS  Google Scholar 

  22. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah YC, Rosenblatt HM, Bradley A, Baldini A (1999) Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379–383

    PubMed  CAS  Google Scholar 

  23. Ludewig K, Geyer MA, Etzensberger M, Vollenweider FX (2002) Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr Res 55:129–137

    Article  PubMed  Google Scholar 

  24. Ludewig K, Geyer MA, Vollenweider FX (2003) Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54:121–128

    Article  PubMed  Google Scholar 

  25. Maren S (2001) Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 24:897–931

    Article  PubMed  CAS  Google Scholar 

  26. McIlwain KL, Merriweather MY, Yuva-Paylor LA, Paylor R (2001) The use of behavioral test batteries: effects of training history. Physiol Behav 73:705–717

    Article  PubMed  CAS  Google Scholar 

  27. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629

    Article  PubMed  CAS  Google Scholar 

  28. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940–945

    Article  PubMed  CAS  Google Scholar 

  29. Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153:1541–1547

    PubMed  CAS  Google Scholar 

  30. Paylor R, McIlwain KL, McAninch R, Nellis A, Yuva-Paylor LA, Baldini A, Lindsay EA (2001) Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet 10:2645–2650

    Article  PubMed  CAS  Google Scholar 

  31. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S et al (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A 103:7728–7734

    Article  CAS  Google Scholar 

  32. Puech A, Saint-Jore B, Merscher S, Russell RG, Cherif D, Sirotkin H, Xu H, Factor S, Kucherlapati R, Skoultchi AI (2000) Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region. Proc Natl Acad Sci U S A 97:10090–10095

    Article  PubMed  CAS  Google Scholar 

  33. Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G et al (1994a) Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: part 2. Am J Med Genet 54:44–50

    Article  PubMed  CAS  Google Scholar 

  34. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D et al (1994b) Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: part 1. Am J Med Genet 54:36–43

    Article  PubMed  CAS  Google Scholar 

  35. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D et al (1994c) Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182:476–478

    Article  PubMed  CAS  Google Scholar 

  36. Rivera-Perez JA, Mallo M, Gendron-Maguire M, Gridley T, Behringer RR (1995) Goosecoid is not an essential component of the mouse gastrula organizer but is required for craniofacial and rib development. Development 121:3005–3012

    PubMed  CAS  Google Scholar 

  37. Rohn RD, Leffell MS, Leadem P, Johnson D, Rubio T, Emanuel BS (1984) Familial third-fourth pharyngeal pouch syndrome with apparent autosomal dominant transmission. J Pediatr 105:47–51

    Article  PubMed  CAS  Google Scholar 

  38. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K, Scambler PJ et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804

    PubMed  CAS  Google Scholar 

  39. Saint-Jore B, Puech A, Heyer J, Lin Q, Raine C, Kucherlapati R, Skoultchi AI (1998) Goosecoid-like (Gscl), a candidate gene for velocardiofacial syndrome, is not essential for normal mouse development. Hum Mol Genet 7:1841–1849

    Article  PubMed  CAS  Google Scholar 

  40. Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421–2426

    Article  PubMed  CAS  Google Scholar 

  41. Scherer NJ, D’Antonio LL, Kalbfleisch JH (1999) Early speech and language development in children with velocardiofacial syndrome. Am J Med Genet 88:714–723

    Article  PubMed  CAS  Google Scholar 

  42. Shprintzen RJ (2000) Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 6:142–147

    Article  PubMed  CAS  Google Scholar 

  43. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D (1978) A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15:56–62

    PubMed  CAS  Google Scholar 

  44. Sporn A, Addington A, Reiss AL, Dean M, Gogtay N, Potocnik U, Greenstein D, Hallmayer J, Gochman P, Lenane M, Baker N, Tossell J, Rapoport JL (2004) 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry 9:225–226

    Article  PubMed  CAS  Google Scholar 

  45. Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M, Gewillig M, Fryns JP (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34:453–458

    Article  PubMed  CAS  Google Scholar 

  46. Wakamiya M, Lindsay EA, Rivera-Perez JA, Baldini A, Behringer RR (1998) Functional analysis of Gscl in the pathogenesis of the DiGeorge and velocardiofacial syndromes. Hum Mol Genet 7:1835–1840

    Article  PubMed  CAS  Google Scholar 

  47. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366–1373

    Article  PubMed  CAS  Google Scholar 

  48. Yamada G, Mansouri A, Torres M, Stuart ET, Blum M, Schultz M, De Robertis EM, Gruss P (1995) Targeted mutation of the murine goosecoid gene results in craniofacial defects and neonatal death. Development 121:2917–2922

    PubMed  CAS  Google Scholar 

  49. Zhu CC, Yamada G, Blum M (1997) Correlation between loss of middle ear bones and altered goosecoid gene expression in the branchial region following retinoic acid treatment of mouse embryos in vivo. Biochem Biophys Res Commun 235:748–753

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIEHS Superfund Center Grant P42 ES10337 to A.W.-B., the American Heart Association, the March of Dimes (1-FY02-193) and the National Institutes of Health (HD34980-08 and DC05186-01) to B.E.M., NIH Grant HD 34980 to R.K., and NIH Grant HD 34980 to A.S.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony Wynshaw-Boris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Long, J.M., LaPorte, P., Merscher, S. et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7, 247–257 (2006). https://doi.org/10.1007/s10048-006-0054-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-006-0054-0

Keywords

Navigation